1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Troponin - Electrolytes/Calcium

Discussion in 'Beckman Coulter' started by Anonymous, Apr 22, 2010 at 6:41 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What is happening with the two FDA recalls? How is B/C able to meet client testing requirements?

  2. Anonymous

    Anonymous Guest

    by splitting samples, adding instruments, and giving shit away to get clients to stay.

    really, they can't - this is why hpg is giving them the boot.
  3. Anonymous

    Anonymous Guest

    hey idiot... HPG just signed a new 5 year dual source agreement with Beckman... get your facts straight or shut up!
  4. Anonymous

    Anonymous Guest

    FDA issues wouldn't have been an issue if Dick Creager weren't leading the initial team. Sounds like the DxN program is also in the toilet - has there been any headway on REAL assays (non-CMV), but wouldn't surprise me if it is pushed to get EU clearance. Good luck defending crap, Hamann. Danaher would be smart to give the diagnostics group up...